Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT04270279
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Registry
-
NCT04270279
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04270279. Randomized; quadruple masking; primary purpose treatment. Start 2020-12 (anticipated); primary completion 2021-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris
- Condition
- Coronary Heart Disease
- Condition
- Stable Angina
- Intervention (Drug)
- Xueshuanxinmaining tablet
- Intervention (Drug)
- Xueshuanxinmaining placebo
- Intervention (Drug)
- Nitroglycerin tablets
- Lead sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Record details
- Record id
cardio:ct-nct04270279- Content hash
6417f33f875277dc25b7ae94a46661c0a49eb15f0ed36aa776d7ffa059cce81c